Login
$GXAI
$0.48 +$0.03 (6.8%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
ASSETS
CURRENT ASSETS:
Cash
Short-term investments, at fair value
Investment in non-traded equity securities, at fair value
Note receivable
Accounts receivable
Prepaid expenses and other current assets
Total Current Assets
LONG-TERM ASSETS:
Property and equipment, net
Intangible assets, net
Digital currencies
Investment in cost method investees
Total Long-Term Assets
TOTAL ASSETS
CURRENT LIABILITIES:
Accounts payable
Accrued expenses
Deferred revenue
Total Current Liabilities
Total Liabilities
STOCKHOLDERS’ EQUITY:
Common stock; par value $0.0001: 50,000,000 shares authorized; 10,744,634 and 7,123,453 shares issued and outstanding on June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total Gaxos.AI Stockholders’ Equity
Noncontrolling interest
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support